FDA ANDA · ANDA210410

BENDAMUSTINE HYDROCHLORIDE

Sponsor: FRESENIUS KABI USA

APPLICATION

ANDA210410

TYPE

ANDA

ROUTE

IV (INFUSION)

DOSAGE FORM

SOLUTION

MARKETING STATUS

None (Tentative Approval)

Products

BENDAMUSTINE HYDROCHLORIDENone (Tentative Approval)

BENDAMUSTINE HYDROCHLORIDE 100MG/4ML (25MG/ML) · SOLUTION · IV (INFUSION)

2018-11-13UNKNOWN · Original · standardTA

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.